Senior Tissue and Data Acquisition Specialist

Associate Director, Alliance Leadership

Future Opportunities: Scientist, Neurodegenerative Disease Modeling and Target Validation

Future Opportunities: Scientist, Target Validation and Exploratory Neurobiology Neurodegeneration

In Vitro Senior Research Associate

In Vitro Scientist/Pharmacology

Head of Translational Biomarkers

Future Opportunities

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

8Biomed

A-Alpha Bio

A2 Biotherapeutics

AavantiBio

AB Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

ACELYRIN

Acepodia

Achieve Life Sciences

Acrivon Therapeutics

Acutis Diagnostics

Adagio Therapeutics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Aditum Bio

adMare BioInnovations

Admera Health

Adverum Biotechnologies

adyn

Aeglea BioTherapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

Affinivax

AgBiome

Agena Bioscience

Akero Therapeutics

Akouos

Alamar Biosciences

Alector

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allakos

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

AllStripes

Alltrna

Alpine Immune Sciences

Altis Biosystems

Alto Neuroscience

AltPep

Alumis

Alveo Technologies

ALX Oncology

Alzheon

Ambagon Therapeutics

Amberstone Biosciences

Ambys Medicines

Amylyx

AN2 Therapeutics

Andes

Angiocrine Bioscience

AnHeart Therapeutics

Annexon Biosciences

Ansa Biotechnologies

Antheia

Apollomics

Appia Bio

Applied Molecular Transport

Apriori Bio (Flagship)

Aptevo Therapeutics

Apton Biosystems

Aptose Biosciences

Aquinnah Pharmaceuticals

Arbor Biotechnologies

Arcadia Science

Arcellx

Arcturus Therapeutics

Arcutis Biotherapeutics

Arima Genomics

Ark Biotech

Arkuda Therapeutics

Armata Pharmaceuticals

Aro Biotherapeutics

Arpeggio Biosciences

Arrakis Therapeutics

Arranta Bio

ArsenalBio

Artisan Bio

Artiva Biotherapeutics

Aruvant

Ascidian Therapeutics

Ascribe Bioscience

Verge Genomics is using machine learning and human genomics to accelerate drug discovery. Technology has the potential to revolutionize drug discovery by making the process cheaper and faster. Verge is capitalizing on this with their ConVERGE platform, which uses machine learning to map the complex causes of disease from their proprietary multi-omics database. Once the cause of disease has been identified, Verge uses their internal biology and chemistry platforms to select proprietary drug candidates that have high probability of clinical success. Verge’s first drug candidate for ALS treatment is expected to enter clinical trials in 2022. Their remaining portfolio includes drug development for Parkinson’s disease and Frontotemporal Dementia patients.

<p>Verge Genomics is using machine learning and human genomics to accelerate drug discovery. Technology has the potential to revolutionize drug discovery by making the process cheaper and faster. Verge is capitalizing on this with their ConVERGE platform, which uses machine learning to map the complex causes of disease from their proprietary multi-omics database. Once the cause of disease has been identified, Verge uses their internal biology and chemistry platforms to select proprietary drug candidates that have high probability of clinical success. Verge’s first drug candidate for ALS treatment is expected to enter clinical trials in 2022. Their remaining portfolio includes drug development for Parkinson’s disease and Frontotemporal Dementia patients.</p>


Verge Genomics

Find a biotech startup job.